研究者一覧

鶴井　敏光Tsurui Toshiaki

■所属部署名	腫瘍内科
■職名	助教(医科)

Last Updated :2026/09/08

Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice, 船山　英治, Biomedicine & Pharmacotherapy, 2025年01月, 原著, 査読あり, DOI:10.1016/j.biopha.2024.117749

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody., Murayama Masakazu;Hosonuma Masahiro;Kuramasu Atsuo;Kobayashi Sei;Sasaki Akiko;Baba Yuta;Narikawa Yoichiro;Toyoda Hitoshi;Isobe Junya;Funayama Eiji;Tajima Kohei;Sasaki Aya;Maruyama Yuki;Yamazaki Yoshitaka;Shida Midori;Hamada Kazuyuki;Hirasawa Yuya;Tsurui Toshiaki;Ariizumi Hirotsugu;Ishiguro Tomoyuki;Suzuki Risako;Ohkuma Ryotaro;Kubota Yutaro;Horiike Atsushi;Sambe Takehiko;Tsuji Mayumi;Wada Satoshi;Kobayashi Shinichi;Shimane Toshikazu;Tsunoda Takuya;Kobayashi Hitome;Kiuchi Yuji;Yoshimura Kiyoshi, Scientific reports, 14(1), 2024年05月, 原著, 査読あり

Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case report., Tsurui Toshiaki;Hirasawa Yuya;Kubota Yutaro;Yoshimura Kiyoshi;Tsunoda Takuya, World journal of gastrointestinal oncology, 16(2), 2024年, 原著, 査読あり

Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment., Hirasawa Yuya;Kubota Yutaro;Mura Emiko;Suzuki Risako;Tsurui Toshiaki;Iriguchi Nana;Ishiguro Tomoyuki;Ohkuma Ryotaro;Shimokawa Masahiro;Ariizumi Hirotsugu;Horiike Atsushi;Wada Satoshi;Ariyoshi Tomotake;Goto Satoru;Otsuka Koji;Murakami Masahiko;Kiuchi Yuji;Yoshimura Kiyoshi;Hoffman Robert M;Tsunoda Takuya, Anticancer research, 44(8):3397 - 3407, 2024年, 原著, 査読あり

Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary., Suzuki Risako;Hamada Kazuyuki;Ohkuma Ryotaro;Homma Mayumi;Tsurui Toshiaki;Iriguchi Nana;Ishiguro Tomoyuki;Hirasawa Yuya;Ariizumi Hirotsugu;Kubota Yutaro;Horiike Atsushi;Yoshimura Kiyoshi;Wada Satoshi;Yamochi Toshiko;Tsunoda Takuya, Frontiers in oncology, 13, 2023年07月, 原著

Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor., Kazuyuki Hamada, Junya Isobe, Kouya Hattori, Masahiro Hosonuma, Yuta Baba, Masakazu Murayama, Yoichiro Narikawa, Hitoshi Toyoda, Eiji Funayama, Kohei Tajima, Midori Shida, Yuya Hirasawa, Toshiaki Tsurui, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Ryotaro Ohkuma, Yutaro Kubota, Takehiko Sambe, Mayumi Tsuji, Satoshi Wada, Yuji Kiuchi, Shinichi Kobayashi, Atsuo Kuramasu, Atsushi Horiike, Yun-Gi Kim, Takuya Tsunoda and Kiyoshi Yoshimura, Front Immunol., 14:1164724, 2023年05月, 原著, 査読あり, DOI:10.3389/fimmu.2023.1164724

Nuclear microRNAs release paused Pol II via the DDX21-CDK9 complex., Shin-Ichiro Ohno; Keiki Oikawa; Toshiaki Tsurui; Yuichirou Harada; Kana Ono; Mizumo Tateishi; Aashiq Mirza; Masakatsu Takanashi; Kosuke Kanekura; Kumiko Nagase; Yoshihisa Shimada; Yujin Kudo; Norihiko Ikeda; Takahiro Ochiya; Xiaozhong Wang; Masahiko Kuroda, Cell reports, 39(2):110673 - 110673, 2022年04月

Nuclear microRNAs release paused Pol II via the DDX21-CDK9 complex., Shin-Ichiro Ohno; Keiki Oikawa; Toshiaki Tsurui; Yuichirou Harada; Kana Ono; Mizumo Tateishi; Aashiq Mirza; Masakatsu Takanashi; Kosuke Kanekura; Kumiko Nagase; Yoshihisa Shimada; Yujin Kudo; Norihiko Ikeda; Takahiro Ochiya; Xiaozhong Wang; Masahiko Kuroda, Cell reports, 39(2):110673 - 110673, 2022年04月

Solitary 15 cm splenic abscess successfully treated with percutaneous drainage., Toshiaki Tsurui; Alan T Lefor; Kauzhiro Nishida, IDCases, 27:e01413, 2022年

Solitary 15 cm splenic abscess successfully treated with percutaneous drainage., Toshiaki Tsurui; Alan T Lefor; Kauzhiro Nishida, IDCases, 27:e01413, 2022年